No Data
No Data
Direct coverage of the Star medical instruments industry collective Earnings Conference: Multiple companies are laying out AI medical Business, and key segments in innovation fields may accelerate the development of domestic production.
① Attending companies believe that tariff policies will bring some cost pressures and market challenges to enterprises, but at the same time, it has accelerated the localization process in relevant fields; ② Some attending companies disclosed the latest developments in their Business during the earnings briefing and the planning for related lines by 2025.
MEDLIVE: ANNUAL REPORT 2024
MEDLIVE (02192.HK): Revenue continues to grow significantly, AI technology empowers Medical digital transformation.
Event: [Company public announcement recently] In 2024, the company achieved revenue of 0.558 billion (+35.44%); gross profit of 0.327 billion (+30.28%); achieved net profit for the parent company.
MEDLIVE (02192.HK): The largest doctor platform in China, with professional content, mature monetization, and long-term high growth.
The largest doctor platform in China provides digital precision marketing solutions. The company has registered over 4 million physicians in China, with a coverage rate of 88%, offering digital marketing solutions to domestic and international Medical enterprises to help expand sales. 20
Express News | The State Administration for Market Regulation will accelerate the development of national standards in the field of AI.
Medlive Technology Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year